NG
NGNE
Neurogene Inc.
$29.10
+0.34%
$459.8M
No data for this timeframe.
Vol
Market Cap$459.8M
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (93%)
Inst. Holders50 funds
Inst. Value$167.4M
Inst. Activity5 buys / 1 sells
Insider Activity0B / 7S
Insider Net $-$542.5K
Reddit Sentiment69° Warm
SEC Reports2
Recent Activity
Jun 8, 2026
SEC
Neurogene announced completion of dosing in the Embolden registrational trial of NGN-401 for Rett syndrome, exceeding th
8-K — Impact 7/10
May 8, 2026
earnings_calendar
NGNE Q1 2026 Earnings Before Market Open — 2026-05-08
May 6, 2026
Insider
Cvijic Christine Mikail sold 4,800 shares
President and CFO @ $30.07 ($144.4K)
May 5, 2026
Insider
Shafer Christina was granted 120,000 shares
Chief Commercial Officer
Apr 20, 2026
SEC
Neurogene Inc. appointed Christine Mikail, its President and CFO, to the Board of Directors and announced Christy Shafer
8-K — Impact 6/10
Mar 26, 2026
Insider
McMinn Rachel sold 3,352 shares
Chief Executive Officer @ $22.07 ($74.0K)
Inst.
FMR LLC — DOUBLED
382,647 shares ($7.7M)
Inst.
RENAISSANCE TECHNOLOGIES LLC — DOUBLED
43,400 shares ($874.9K)
Price Targets
$80.00
+174.9% upside
Strong Buy
Current $29.10
Low $46.00
Median $69.00
High $180.00
7 analysts
$46.00
$180.00
Analyst Ratings
6Strong Buy
8Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 9, 2026 | HC Wainwright & Co. | REITERATE | Buy → Buy |
| Apr 6, 2026 | Canaccord Genuity | MAINTAIN | Buy → Buy |
| Feb 27, 2026 | Canaccord Genuity | INITIATE | Buy |
| Jan 26, 2026 | LifeSci Capital | INITIATE | Outperform |
| Jan 13, 2026 | HC Wainwright & Co. | REITERATE | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-1.39 | $-1.50 — $-1.30 | -32% YoY | 6 |
| Next Q | $-1.31 | $-1.50 — $-1.06 | -32% YoY | 6 |
| Current FY | $-5.41 | $-5.89 — $-4.88 | -28% YoY | 6 |
| Next FY | $-5.59 | $-5.92 — $-4.69 | -3% YoY | 4 |
Latest Reports
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| RTW INVESTMENTS, LP | $27.5M | — |
| BlackRock, Inc. | $20.3M | — |
| BAKER BROS. ADVISORS LP | $20.0M | TRIM |
| BALYASNY ASSET MANAGEMENT L.P. | $14.5M | NEW |
| TORONTO DOMINION BANK | $13.7M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 6, 2026 | Cvijic Christine | SELL | $144.4K |
| May 5, 2026 | Shafer Christina | A | $0.00 |
| Mar 26, 2026 | McMinn Rachel | SELL | $74.0K |
| Mar 26, 2026 | Jordan Julie | SELL | $18.1K |
| Mar 26, 2026 | Cvijic Christine | SELL | $55.3K |
Reddit Sentiment
69°
Warm
Bearish
Neutral
Bullish
50 institutional holders with $167.4M total value (8,304,021 shares) as of 2026-Q1. Top holders: RTW, BlackRock,, BAKER. Net buying activity: 5 institutions added/increased vs 1 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | RTW INVESTMENTS, LP | 1,362,456 | $27.5M | 16.4% | — |
| 2 | BlackRock, Inc. | 1,005,070 | $20.3M | 12.1% | — |
| 3 | BAKER BROS. ADVISORS LP | 991,691 | $20.0M | 11.9% | TRIM -33.3% |
| 4 | BALYASNY ASSET MANAGEMENT L.P. | 718,389 | $14.5M | 8.7% | NEW |
| 5 | TORONTO DOMINION BANK | 681,337 | $13.7M | 8.2% | — |
| 6 | JENNISON ASSOCIATES LLC | 527,685 | $10.6M | 6.4% | ADD +35.3% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 514,727 | $10.4M | 6.2% | — |
| 8 | CITADEL ADVISORS LLC | 387,031 | $7.8M | 4.7% | — |
| 9 | FMR LLC | 382,647 | $7.7M | 4.6% | DOUBLED +193.6% |
| 10 | STATE STREET CORP | 313,005 | $6.3M | 3.8% | ADD +47.8% |
| 11 | MORGAN STANLEY | 285,239 | $5.8M | 3.4% | — |
| 12 | BLAIR WILLIAM & CO/IL | 168,218 | $3.4M | 2.0% | DOUBLED +141.3% |
| 13 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 125,900 | $2.5M | 1.5% | — |
| 14 | GOLDMAN SACHS GROUP INC | 107,714 | $2.2M | 1.3% | — |
| 15 | DEUTSCHE BANK AG\ | 106,255 | $2.1M | 1.3% | — |
| 16 | Woodline Partners LP | 83,835 | $1.7M | 1.0% | — |
| 17 | VANGUARD FIDUCIARY TRUST CO | 69,712 | $1.4M | 0.8% | — |
| 18 | VANGUARD PORTFOLIO MANAGEMENT LLC | 65,080 | $1.3M | 0.8% | — |
| 19 | SCHRODER INVESTMENT MANAGEMENT GROUP | 52,300 | $1.0M | 0.6% | ADD +73.3% |
| 20 | RENAISSANCE TECHNOLOGIES LLC | 43,400 | $874.9K | 0.5% | DOUBLED +210.0% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| FMR LLC | DOUBLED | 130,329 | 382,647 | +193.6% | $7.7M | 2026-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 14,000 | 43,400 | +210.0% | $874.9K | 2026-Q1 |
| BANK OF AMERICA CORP /DE/ | TRIM | 41,759 | 10,864 | -74.0% | $219.0K | 2026-Q1 |
| Russell Investments Group, Ltd. | ADD | 856 | 1,607 | +87.7% | $32.4K | 2026-Q1 |
| CWM, LLC | DOUBLED | 154 | 1,030 | +568.8% | $20.8K | 2026-Q1 |
| NISA INVESTMENT ADVISORS, LLC | ADD | 45 | 63 | +40.0% | $1.3K | 2026-Q1 |
| JENNISON ASSOCIATES LLC | ADD | 394,089 | 533,088 | +35.3% | $11.0M | 2025-Q4 |
| STATE STREET CORP | ADD | 208,310 | 307,797 | +47.8% | $6.3M | 2025-Q4 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | ADD | 30,177 | 52,300 | +73.3% | $1.2M | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 20,551 | 11,991 | -41.7% | $247.0K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 7,599 | 11,037 | +45.2% | $227.4K | 2025-Q4 |
| Mirae Asset Global Investments Co., Ltd. | ADD | 552 | 753 | +36.4% | $15.5K | 2025-Q4 |
| BALYASNY ASSET MANAGEMENT L.P. | NEW | — | 699,002 | — | $12.1M | 2025-Q3 |
| JENNISON ASSOCIATES LLC | DOUBLED | 167,563 | 394,089 | +135.2% | $6.8M | 2025-Q3 |
| FMR LLC | NEAR_EXIT | 468,476 | 115,550 | -75.3% | $2.0M | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | TRIM | 95,401 | 40,553 | -57.5% | $702.8K | 2025-Q3 |
| Russell Investments Group, Ltd. | DOUBLED | 41 | 856 | +1987.8% | $14.8K | 2025-Q3 |
| BAKER BROS. ADVISORS LP | TRIM | 1,486,200 | 991,691 | -33.3% | $14.8M | 2025-Q2 |
| JENNISON ASSOCIATES LLC | ADD | 108,084 | 167,563 | +55.0% | $2.5M | 2025-Q2 |
| WELLINGTON MANAGEMENT GROUP LLP | ADD | 34,421 | 44,904 | +30.5% | $671.3K | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | ADD | 10,844 | 20,497 | +89.0% | $306.4K | 2025-Q2 |
| PNC FINANCIAL SERVICES GROUP, INC. | ADD | 2,823 | 4,055 | +43.6% | $60.6K | 2025-Q2 |
| ROYAL BANK OF CANADA | DOUBLED | 514 | 1,120 | +117.9% | $16.0K | 2025-Q2 |
| Legal & General Group Plc | TRIM | 1,230 | 898 | -27.0% | $13.4K | 2025-Q2 |
| NISA INVESTMENT ADVISORS, LLC | NEAR_EXIT | 1,253 | 45 | -96.4% | $673.00 | 2025-Q2 |
10 unique insiders with 20 transactions. Net insider value: -$542.5K ($0.00 bought, $542.5K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 6, 2026 | Cvijic Christine Mikail | President and CFO | SELL | 4,800 | $30.07 | $144.4K |
| May 5, 2026 | Shafer Christina | Chief Commercial Officer | AWARD | 120,000 | — | — |
| Mar 26, 2026 | McMinn Rachel | Chief Executive Officer | SELL | 3,352 | $22.07 | $74.0K |
| Mar 26, 2026 | Jordan Julie | Chief Medical Officer | SELL | 828 | $21.89 | $18.1K |
| Mar 26, 2026 | Cvijic Christine Mikail | President and CFO | SELL | 2,558 | $21.62 | $55.3K |
| Mar 13, 2026 | Cvijic Christine Mikail | President and CFO | SELL | 2,387 | $20.42 | $48.7K |
| Mar 13, 2026 | Cobb Stuart | Chief Scientific Officer | SELL | 3,991 | $20.41 | $81.5K |
| Feb 27, 2026 | Cvijic Christine Mikail | President and CFO | SELL | 4,800 | $25.11 | $120.5K |
| Feb 20, 2026 | Jordan Julie | Chief Medical Officer | AWARD | 4,900 | — | — |
| Feb 20, 2026 | McMinn Rachel | Chief Executive Officer | AWARD | 25,900 | — | — |
| Feb 20, 2026 | McMinn Rachel | Chief Executive Officer | AWARD | 155,100 | — | — |
| Feb 20, 2026 | Cvijic Christine Mikail | President and CFO | AWARD | 131,900 | — | — |
| Feb 20, 2026 | Cvijic Christine Mikail | President and CFO | AWARD | 22,000 | — | — |
| Feb 20, 2026 | Freedland Cory S. | Director | AWARD | 12,050 | — | — |
| Feb 20, 2026 | Cobb Stuart | Chief Scientific Officer | AWARD | 16,500 | — | — |
| Feb 20, 2026 | Jordan Julie | Chief Medical Officer | AWARD | 29,600 | — | — |
| Feb 20, 2026 | PALEKAR ROHAN | Director | AWARD | 12,050 | — | — |
| Feb 20, 2026 | BAFFI ROBERT | Director | AWARD | 12,050 | — | — |
| Feb 20, 2026 | Noonberg Sarah B. | Director | AWARD | 12,050 | — | — |
| Feb 20, 2026 | Woods Keith | Director | AWARD | 12,050 | — | — |
2 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 1 mixed, 0 neutral. Avg impact: 6.5/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (93% buy). Based on 15 analysts: 6 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$80.00 mean target
+174.9% upside
Strong Buy (1.00)
$46.00 Low
$180.00 High
| Metric | Value |
|---|---|
| Current Price | $29.10 |
| Target Low | $46.00 |
| Target Mean | $80.00 |
| Target Median | $69.00 |
| Target High | $180.00 |
| # Analysts | 7 |
| Recommendation | Strong Buy (1.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-1.39 | $-1.50 | $-1.30 | -31.9% | — | 0↑ 5↓ | $0.0B | 0.0% | 6 |
| Next Q 2026-09-30 |
$-1.31 | $-1.50 | $-1.06 | -32.0% | — | 1↑ 4↓ | $0.0B | 0.0% | 6 |
| Current FY 2026-12-31 |
$-5.41 | $-5.89 | $-4.88 | -27.5% | — | 1↑ 4↓ | $0.0B | 0.0% | 6 |
| Next FY 2027-12-31 |
$-5.59 | $-5.92 | $-4.69 | -3.4% | — | 1↑ 2↓ | $0.0B | 0.0% | 4 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-1.385 | |
| 7d ago | $-1.385 | |
| 30d ago | $0.000 | -1.385 |
| 60d ago | $-1.212 | -0.173 |
| 90d ago | $-1.258 | -0.127 |
3 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 2 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 9, 2026 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Apr 6, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| Feb 27, 2026 | Canaccord Genuity | INITIATE | — | Buy |
| Jan 26, 2026 | LifeSci Capital | INITIATE | — | Outperform |
| Jan 13, 2026 | HC Wainwright & Co. | REITERATE | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 6 | 8 | 1 | 0 | 0 | 93% | |
| May 1, 2026 | 6 | 8 | 1 | 0 | 0 | 93% | |
| Apr 1, 2026 | 5 | 8 | 1 | 0 | 0 | 93% | |
| Mar 1, 2026 | 5 | 8 | 1 | 0 | 0 | 93% | |
| Feb 1, 2026 | 5 | 6 | 1 | 0 | 0 | 92% | |
| Jan 1, 2026 | 5 | 6 | 1 | 0 | 0 | 92% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
69°
Warm
Bearish
Neutral
Bullish
4 mentions
3 bullish
0 bearish
3 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| May 5, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Apr 22, 2026 | 2 | 67° Warm | 2 | 0 | 2 |
| Apr 22, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
Portfolio feedback request.
▲ 1
💬 0
⚡ 0.5
NGNE squeeze??
▲ 1
💬 0
⚡ 0.5
Next Squeeze: NGNE
▲ 1
💬 0
⚡ 0.5
May 8, 2026
earnings_calendar
NGNE Q1 2026 Earnings Before Market Open — 2026-05-08
Apr 16, 2026
short_interest
FTD: NGNE — 48,713 shares ($1.2M) failed to deliver
Settlement: 20260416, Price: $24.00, FTD Value: $1,169,112, NEUROGENE INC COM
Mar 23, 2026
earnings_calendar
NGNE Q4 2025 Earnings After Market Close — 2026-03-23